subject_id=OCCAMS/PS/019;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/019;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/013;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/013;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/023;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/023;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/017;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/005;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/009;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/019;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/013;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/023;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/010;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/011;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/014;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/047;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/071;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/023;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/011;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/014;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/047;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/071;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/023;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/011;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/AH/159;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/AH/271;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/AH/283;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/AH/284;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/AH/286;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/AH/296;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/ED/088;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/NN/033;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=OCCAMS/NN/059;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=OCCAMS/ED/105;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/ED/106;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=OCCAMS/ED/107;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/ED/120;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/GS/018;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/AH/242;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/022;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/NT/004;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/NT/001;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/093;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/061;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/120;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/041;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/029;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/009;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/009;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/008;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/008;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/003;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/003;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/001;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/001;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/002;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/002;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/012;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/012;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/013;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/013;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/014;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/014;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/015;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/015;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/010;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/010;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/011;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PS/011;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/017;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/017;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/005;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/005;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/019;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/019;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/029;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/034;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/131;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/136;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/003;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/049;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/052;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/058;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/006;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/030;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/109;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/033;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/008;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/139;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/140;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/026;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/001;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/031;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/019;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/QE/081;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/011;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/062;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/022;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/014;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/167;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/143;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/020;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/035;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/002;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/024;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/025;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SA/013;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/024;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/031;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/036;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/032;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/091;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/183;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/182;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/117;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/046;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/QE/095;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PL/002;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/056;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/142;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/115;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/022;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/111;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/074;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/015;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/026;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/033;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/036;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/039;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/041;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/043;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/064;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/082;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/085;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/086;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/088;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/003;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/016;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/019;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/020;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/024;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/002;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/008;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/122;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/127;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/173;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/021;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/033;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/005;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/007;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/008;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/009;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/011;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/004;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/007;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/009;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/014;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/016;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/017;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/020;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/077;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/042;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/048;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/046;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/069;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/012;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/013;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/014;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/015;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/036;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/010;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/001;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/133;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/016;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/040;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/007;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/006;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/108;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/071;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/026;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/135;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/013;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/043;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/138;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/041;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/042;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/155;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/160;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/027;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/028;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/045;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/146;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/029;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/075;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/084;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/094;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/096;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/QE/062;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/038;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/051;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/014;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/001;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/002;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/005;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/006;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/009;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/019;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/027;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/100;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/020;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/016;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/NT/004;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/NT/001;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/093;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/029;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/034;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/049;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/052;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/058;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/006;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/109;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/033;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/026;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/001;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/031;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/QE/081;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/020;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/025;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SA/013;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/024;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/117;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/046;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/PL/002;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/056;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/142;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/115;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/022;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/022;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/111;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/111;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/111;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/074;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/074;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/015;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/026;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/033;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/041;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/043;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/016;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/019;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/002;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/122;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/122;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/122;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/033;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/005;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/008;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/009;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/011;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/007;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/014;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/017;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/020;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/069;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/012;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/013;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/014;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/015;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/001;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/016;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/040;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/026;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/013;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/138;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/042;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/045;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/075;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/084;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/094;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/QE/062;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/014;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/027;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/100;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/016;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/134;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/147;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/156;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/210;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/006;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/058;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/061;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/UC/005;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/UC/006;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/062;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/070;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/121;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/126;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/UC/001;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/193;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/057;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/169;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/137;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/180;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/194;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/198;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/200;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/204;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/234;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/236;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/041;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/045;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/046;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/048;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/049;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/054;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/218;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/009;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/016;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/NT/048;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SA/029;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/093;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/245;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/246;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/248;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/255;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OCCAMS/AH/065;subject_id=OCCAMS/AH/065;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/AH/238;subject_id=OC/AH/238;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/AH/266;subject_id=OC/AH/266;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/AH/277;subject_id=OC/AH/277;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/ED/010;subject_id=OC/ED/010;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/ED/089;subject_id=OC/ED/089;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/ED/061;subject_id=OC/ED/061;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/NN/026;subject_id=OC/NN/026;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/NN/030;subject_id=OC/NN/030;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/AH/271;subject_id=OC/AH/271;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/AH/159;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/AH/283;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/AH/284;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/AH/286;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/AH/296;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/ED/088;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/NN/033;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=OCCAMS/NN/059;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=OCCAMS/ED/105;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/ED/106;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=OCCAMS/ED/107;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/ED/120;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/GS/018;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/AH/244;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/AH/312;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/ED/121;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/ED/132;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/ED/139;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/AH/334;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/QE/148;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/ST/081;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/ST/101;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=OCCAMS/AH/338;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=tumor;subject_id=OCCAMS/AH/292;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/035;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/036;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/037;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/112;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/063;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/134;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/147;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/156;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/174;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/196;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/197;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/210;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/213;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/047;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/006;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/058;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/061;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/UC/005;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/UC/006;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/062;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/070;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/121;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/126;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/UC/001;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/193;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/057;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/169;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/137;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/180;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/194;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/198;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/200;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/204;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/234;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/236;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/041;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/045;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/046;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/048;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/049;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/054;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/218;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/009;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/016;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/NT/048;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SA/029;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/093;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/245;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/248;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/255;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OCCAMS/AH/065;subject_id=OCCAMS/AH/065;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/AH/238;subject_id=OC/AH/238;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/AH/266;subject_id=OC/AH/266;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/AH/277;subject_id=OC/AH/277;gender=female;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/ED/010;subject_id=OC/ED/010;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/ED/089;subject_id=OC/ED/089;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/ED/061;subject_id=OC/ED/061;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/NN/026;subject_id=OC/NN/026;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/NN/030;subject_id=OC/NN/030;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
anonymized_name=OC/AH/246;subject_id=OC/AH/246;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/AH/244;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/AH/312;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/ED/121;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/ED/132;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/ED/139;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/AH/334;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/QE/148;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/ST/081;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=non-tumor;subject_id=OCCAMS/ST/101;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=OCCAMS/AH/338;ENA-CHECKLIST=ERC000026;
gender=female;phenotype=non-tumor;subject_id=OCCAMS/AH/292;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/036;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/039;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/064;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/082;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/085;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/086;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/088;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/003;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/020;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/024;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/008;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/061;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/120;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/041;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/029;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/131;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/136;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/003;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/030;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/008;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/139;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/140;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/019;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/011;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/062;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/022;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/014;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/167;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/143;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/035;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/GS/002;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/024;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/031;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/036;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/032;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/091;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/183;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/182;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/QE/095;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/127;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/173;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/021;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/007;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/004;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/009;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ZZ/016;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/077;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/042;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/048;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/046;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/036;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/010;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/133;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/007;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/006;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/108;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/071;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/135;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/043;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/041;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/155;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/160;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/027;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/028;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/146;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/029;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/096;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/038;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/SH/051;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/001;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/002;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/005;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/006;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/009;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/WG/019;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/020;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/033;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/035;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/036;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/037;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/112;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/063;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/174;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/196;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/197;gender=female;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/AH/213;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/RS/047;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
gender=male;phenotype=tumor;subject_id=OCCAMS/AH/242;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ED/022;gender=male;phenotype=tumor;ENA-CHECKLIST=ERC000026;
subject_id=OCCAMS/ST/033;gender=male;phenotype=non-tumor;ENA-CHECKLIST=ERC000026;
